Solon, OH, United States of America

Santhosh Vadivelu

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2023

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Santhosh Vadivelu: Innovator in Cancer Treatment

Introduction

Santhosh Vadivelu is a notable inventor based in Solon, OH (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented compositions. With a total of 2 patents, Vadivelu is dedicated to advancing medical science and improving patient outcomes.

Latest Patents

Vadivelu's latest patents focus on compositions containing decitabine, 5-azacytidine, and tetrahydrouridine. These compositions are designed for the treatment of cancer and are administered in pill form to human subjects. The administration is guided by the measurement of predictive biomarkers, allowing for a more personalized approach to treatment. His work emphasizes the importance of combining these compounds to enhance therapeutic efficacy.

Career Highlights

Santhosh Vadivelu is currently associated with Epidestiny, Inc., where he continues to develop innovative solutions for cancer treatment. His research has the potential to change the landscape of oncology, providing new hope for patients battling this disease.

Collaborations

Vadivelu collaborates with esteemed colleagues such as Yogen Saunthararajah and Joseph Desimone. Together, they work towards advancing the understanding and treatment of cancer through innovative research.

Conclusion

Santhosh Vadivelu is a pioneering inventor whose work in cancer treatment is making a significant impact. His dedication to innovation and collaboration in the field of medicine is commendable and holds promise for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…